Je was op zoek naar: general notes for presenters (Deens - Nederlands)

se technical notes for guidance on product evaluation.
zie technical notes for guidance on product evaluation.

note for guidance:
note for guidance:

note for guidance on carcinogenic potential
note for guidance on carcinogenic potential

annex to note for guidance:
annex to note for guidance:

revised note for guidance on repeated dose toxicity
revised note for guidance on repeated dose toxicity

note for guidance on quality of herbal medicinal products
note for guidance on quality of herbal

draft note for guidance on impurities in new medicinal products
draft note for guidance on impurities in new medicinal products

note for guidance on development pharmaceutics for veterinary medicinal products.
note for guidance on development pharmaceutics for veterinary medicinal products

addendum to note for guidance on plasma- derived medicinal products
addendum to note for guidance on plasma-derived medicinal products

annex to note for guidance on stability testing of new active substances and medicinal products.
annex to note for guidance on stability testing of new active substances and medicinal products.

annex to note for guidance on stability testing of existing active substances and related finished products.
annex to note for guidance on stability testing of existing active substances and related finished products.

der kunne derfor ikke fastsættes en tilbageholdelsestid som foreskrevet i "note for guidance:
de statistische (hoge extrapolatie) noch de alternatieve methode (waarden boven de mrl op het laatste tijdstip) kon op de verstrekte gegevens worden toegepast, en derhalve kon geen wachttijd worden vastgesteld overeenkomstig de “ note for guidance:

note for guidance on the clinical investigation of human normal immunoglobulin for intravenous administration (ivig)
investigation of human normal

note for guidance on modified release oral and transdermal dosage forms: section ii (quality)
note for guidance on modified release oral and transdermal dosage forms: section ii (quality)

titel på dokumentet annex to note for guidance on development pharmaceutics (cpmp/ qwp/ 155/ 96):
titel document annex to note for guidance on development pharmaceutics (cpmp/qwp/155/96):